In the third quarter of 2021, medical device company M&A values reached $7.1bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $6.7bn.

Exclusive online-only content>>>Amerigo Labs is making the New Shaker delivery device – backed by 25 years of market experience in Europe – available in the U.S. as a potentially game-changing technology for manufacturers of drugs, dietary supplements, energy drinks, food and personal-care products. For nutricosmetics firms that market ingestible powder-based products, the packaging innovation could help differentiate offerings from competitors’ products.

Amerigo Labs is making the New Shaker delivery device available in the U.S. as a potentially market-changing technology for firms including drug, dietary supplement, energy drink, food and personal care product manufacturers. Amerigo launched nutritional products subsidiary Amazing 1-Shot to introduce New Shaker to consumers.

Amerigo Labs is making the New Shaker delivery device available in the U.S. as a potentially market-changing technology for firms including drug, dietary supplement, energy drink, food and personal care product manufacturers. Amerigo launched nutritional products subsidiary Amazing 1-Shot to introduce New Shaker to consumers.